DLX6 and Familial prostate cancer: We found clear evidence that DLX6-AS1 contributed to the progression of prostate cancer by accelerating malignant phenotypes of cells and lymph node metastasis through facilitating the DNMT1-mediated LARGE methylation (Figure 6).